Wave Life Sciences (WVE) Net Income towards Common Stockholders (QoQ) (2014 - 2026)
Wave Life Sciences (WVE) Net Income towards Common Stockholders (QoQ) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Wave Life Sciences | 1.19 Bn | 649.41 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 50.94% |
| Dec 31, 2025 | 1.25% |
| Sep 30, 2025 | -6.70% |
| Jun 30, 2025 | -7.66% |
| Mar 31, 2025 | -260.25% |
| Dec 31, 2024 | 147.35% |
| Sep 30, 2024 | -87.65% |
| Jun 30, 2024 | -4.33% |
| Mar 31, 2024 | -93.86% |
| Dec 31, 2023 | -324.48% |
| Sep 30, 2023 | 134.36% |
| Jun 30, 2023 | 22.99% |
| Mar 31, 2023 | 37.30% |
| Dec 31, 2022 | -12.06% |
| Sep 30, 2022 | 5.55% |
| Jun 30, 2022 | -9.21% |
| Mar 31, 2022 | -8.70% |
| Dec 31, 2021 | -458.41% |
| Sep 30, 2021 | 83.93% |
| Jun 30, 2021 | 8.71% |